Related Experiment Video
Updated: Jul 9, 2026
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Alexithymia and interleukin variations in somatoform disorder
Francisco Pedrosa Gil1, Marius Nickel, Nathan Ridout
1Psychosomatic Ambulance and Outpatient Clinic, Department of Internal Medicine Innenstadt, Ludwig Maximilians University, Munich, Germany. Francisco.Pedrosa.Gil@med.uni-muenchen.de
Neuroimmunomodulation
|December 13, 2007
Summary
Somatoform disorders (SFD) are linked to altered immune responses, specifically increased IL-6 and IL-10 serum levels. Alexithymia severity in SFD patients correlates with changes in immune markers like sIL-2 Ralpha.
Area of Science:
- Immunology
- Psychiatry
- Medical Psychology
Background:
- Somatoform disorders (SFD) are characterized by physical symptoms without a clear medical explanation.
- Interleukin levels play a crucial role in immune system regulation.
- Alexithymia, difficulty identifying and expressing emotions, is often associated with somatic symptom disorders.
Purpose of the Study:
- To investigate the association between somatoform disorders (SFD) and serum levels of key interleukins.
- To determine if changes in interleukin levels correlate with the presence and severity of alexithymia in SFD patients.
Main Methods:
- Serum concentrations of soluble interleukin 2 receptor alpha (sIL-2 Ralpha), IL-4, IL-6, IL-10, and IL-12 were measured.
- Twenty-four unmedicated SFD patients and 9 healthy controls participated.
- Psychological assessments included the Toronto Alexithymia Scale and SCL-90-R.
Main Results:
- SFD patients exhibited significantly higher serum levels of IL-6, IL-10, and immunoglobulin E compared to healthy controls.
- A negative correlation was found between alexithymia total score and serum sIL-2 Ralpha levels in SFD patients.
- No significant differences were observed in IL-4 and IL-12 levels between groups.
Conclusions:
- SFD with clinically significant alexithymia is associated with reduced Th1-mediated immune function.
- An increase in Th2 immune function activation is indicated by elevated IL-6, IL-10, and immunoglobulin E levels in SFD.
- These findings suggest a link between immune dysregulation and emotional processing deficits in somatoform disorders.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Dissociative Identity Disorder
Dissociative Identity Disorder (DID), previously termed multiple personality disorder, is a complex psychological condition characterized by the presence of two or more distinct identities or personality states. Each identity exhibits unique patterns of behavior, voice, and mannerisms and may possess separate memories and emotional responses. The alternating control between identities can result in memory gaps and challenges in recalling daily activities, often exacerbating the individual's...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:18Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...